• Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades, and initiations, please see our analyst ratings page.
• Evercore ISI Group analyst Vijay Kumar upgraded Guardant Health Inc (NASDAQ:GH) from In-Line to Outperform and raised the price target from $95 to $160. Guardant Health shares closed at $129.14 on Tuesday. See how other analysts view this stock.
• BofA Securities analyst Ernesto Gabilondo upgraded Grupo Cibest SA ADR (NYSE:CIB) from Underperform to Neutral and raised the price target from $68 to $75. Grupo Cibest shares closed at $73.37 on Tuesday. See how other analysts view this stock.

Considering buying GH stock? Here’s what analysts think:

Disclaimer:This article represents the opinion of the author only. It does not represent the opinion of Webull, nor should it be viewed as an indication that Webull either agrees with or confirms the truthfulness or accuracy of the information. It should not be considered as investment advice from Webull or anyone else, nor should it be used as the basis of any investment decision.